TherapeuticsMD Balance Sheet - Quarterly (NASDAQ:TXMD)

Add to My Stocks
$6.22 $0.1 (1.63%) TXMD stock closing price Sep 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at TherapeuticsMD balance sheet. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our TherapeuticsMD stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. TherapeuticsMD balance sheet as at the end of 2018 Q2 indicates an asset turnover ratio of 0.1 and debt to equity ratio of 0.94. Also check TherapeuticsMD revenue and TherapeuticsMD operating cash flow for the same period.

View and download TherapeuticsMD quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods1.65M1.62M1.48M1.29M1.39M1.32M1.06M---
Notes Receivable----------
Other Current Assets5.2M5.09M6.6M3M2.22M2.48M2.29M2.69M2.13M1.71M
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets---------1.17M
Total Assets
Notes Payable-------2.35M--
Accounts Payable11.43M6.28M4.09M4.19M8.1M6.14M7.35M4.22M3.03M3.43M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses9.79M---------
Income Taxes Payable----------
Other Current Liabilities-9.37M9.22M6.67M5.18M7.94M7.62M8.24M6.29M6.16M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt73.14M---------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus521.61M518.14M516.35M514.49M443.95M441.02M436.99M433.02M428.9M423.93M
Retained Earnings-444.28M-411.06M-386.65M-365.23M-350.56M-330.89M-309.7M-286.86M-261.85M-240.75M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity77.55M107.3M129.9M149.48M93.58M110.33M127.48M146.35M167.24M183.37M
Total Liabilities & Shareholders Equity171.9M122.96M143.22M160.36M106.87M124.42M142.47M158.82M176.58M192.96M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the TherapeuticsMD stock price, and TherapeuticsMD historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the TherapeuticsMD PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like TherapeuticsMD owns and has monetary significance. TXMD assets grew from $122.96M in 2018 Q1 to $171.9M in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: The total liabilities of TherapeuticsMD for the quarter 2018 Q2 total to $94.35M. Liabilities for a company like TherapeuticsMD include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

TherapeuticsMD Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio